{"date":"2025-04-14","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2025-04-14-1853-1ih3356","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-14","time":"18:53:25","subject":"代子公司Polaris Pharmaceuticals, Inc.公告與Er-Kim Pharmaceuticals簽訂商業化及通路銷售合作合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-14 18:53，「代子公司Polaris Pharmaceuticals, Inc.公告與Er-Kim Pharmaceuticals簽訂」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-04-14-1853-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-04-14","time":"18:53:01","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2025-04-14","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-04-14 18:53，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-14-1838-1puvlj0","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-14","time":"18:38:35","subject":"代子公司Polaris Pharmaceuticals, Inc.公告與Tabuk Pharmaceutical Manufacturing Company簽訂條件式商業化及通路銷售合作合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-14 18:38，「代子公司Polaris Pharmaceuticals, Inc.公告與Tabuk Pharmaceutical Man」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-04-14-1813-1mftmr7","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-04-14","time":"18:13:52","subject":"代子公司共信醫療器材股份有限公司與G公司簽訂本公司產品樂安醫藥外敷凝膠台灣總經銷協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-04-14 18:13，「代子公司共信醫療器材股份有限公司與G公司簽訂本公司產品樂安醫藥外敷凝膠台灣總經銷協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-04-14-1812-9gik8f","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-04-14","time":"18:12:29","subject":"114年第一季財務報告董事會預計召開日期為114年04月21日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-04-14 18:12，「114年第一季財務報告董事會預計召開日期為114年04月21日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-04-14-1802-1v75xhv","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-04-14","time":"18:02:06","subject":"公告本公司114年第一次私募普通股收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-04-14 18:02，「公告本公司114年第一次私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-14-1743-gi3647","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-14","time":"17:43:14","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-14 17:43，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-14-1742-5e664a","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-14","time":"17:42:56","subject":"本公司董事會決議分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-14 17:42，「本公司董事會決議分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-14-1742-1hku5w3","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-14","time":"17:42:27","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-14 17:42，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-14-1733-1fw8kus","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-14","time":"17:33:27","subject":"公告更正本公司2023年董事酬金","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-14 17:33，「公告更正本公司2023年董事酬金」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-04-14-1724-x6b7kl","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-04-14","time":"17:24:46","subject":"公告董事會決議買回本公司股份","clause":"第35款","fact_date":"2025-04-14","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-04-14 17:24，「公告董事會決議買回本公司股份」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-04-14-1717-pr08lc","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-04-14","time":"17:17:14","subject":"公告本公司庫藏股買回達一定標準申報","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-04-14 17:17，「公告本公司庫藏股買回達一定標準申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-04-14-1552-1rfnz8s","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-04-14","time":"15:52:49","subject":"本公司113年度限制員工權利新股延後發行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-04-14 15:52，「本公司113年度限制員工權利新股延後發行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-04-14-1414-1h3ceio","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-04-14","time":"14:14:28","subject":"公告本公司董事會決議買回庫藏股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-04-14 14:14，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}